ひな☆彡 SOXL : You convinced me. I am happy to buy some later.

Growth Investor27 : Long ESPR $1.61 is very cheap.

Growth Investor27 : Long150,000 will hold for 5x upside for 2025 if not aquired.

Tonyco : Nice write-up! I picked ESPR because they just began revenue generation, and the earnings call explained Q2 only had a couple months of sales included.
Good to know it's a much better picture for them than  I was aware. Didn't know Statin drugs were so vital!

JERRY_ONG : Well, a good stock don't need ADs every where. Wish you the best anyway.

Deep Sea : This is high risk stock. No guarantee this company will be bought over.

Deep Sea : I prefer Pfizer that has exists for more than 100 years. It is a strong fundamental company. The dividend yield is more than 5%. I prefer to buy and hold a known and stable stock.

10xStockPicks OP Deep Sea : Its actually not high risk because it has a strong balance sheet & is trading well below intrinsic value. You are missing the point here, anyone that wants a serious upside return needs to invest in companies before the growth curve. Esperion has the product & is in a huge market space. $PFE is slow growth

Growth Investor27 : Japan news should be very soon. I know Otsuka is very excited to be selling these statin alternatives drugs. ESPR will do very well.

Tonyco Deep Sea : Wouldn't say high risk - only because already started selling the drugs. Before FDA approval I would agree.